Enzymes
are proteins naturally produced by living organisms that stimulate and speed up
bio-chemical reactions. These prove beneficial in building new cells, repairing
damaged ones in the blood and tissues of organisms. As these are multifunctional
and have high specificity, they find widespread applications in pharmaceutical
industries, in diagnosing chronic diseases and in the treatment of various
ailments including cancer, cardiovascular diseases and more. Several Industrial
and household catalysis depends on the activity of enzymes as they lower
activation energy and improve manufacturing efficiencies. Besides, they are
cost effective and act as eco-friendly catalysts in various industrial, environmental
and consumer products.
Specialty
enzymes are proteins that are used in pharma, biotech & diagnostics, and
act as biocatalysts in reaction, accelerating the pace of reactions thus acting
as a cost-effective and eco-friendly entity in industrial and environmental
products. Specialty enzymes find immense applications in areas such as
molecular biology and creating molecules that have effective therapeutic uses. These
enzymes are recommended by doctors to control incidences of digestive
disorders, recent clinical trials point towards reliable evidences in being
used as treatment therapy for diseases like cancer. Administered individually
or with other treatments specialty enzymes such as prolactazyme, collagenase treats
skin ulcer. Enzymes like asparaginase and streptokinase are used to treat
various diseases. These enzymes are used in small amounts in therapeutics so
that they do not cause any side effect. Furthermore, they must be highly purified
and have a high degree of specificity. For instance alkaline phosphatase and
peroxides are used in immunoassays.
Recently,
researchers at the Centenary Institute in Sydney have uncovered new information
about an enzyme called DPP9. They believe DPP9 is a potential therapeutic
target and limits the growth of cancerous cells in liver. Currently, the molecule
is highly powerful and needs to be externally regulated. Researches are also
trying to ascertain how the cells of the body can achieve this naturally. Professor
Mark Gorrell, who is behind the discovery of DPP9, is currently researching on
the functionalities of the enzyme. There are other such endeavors
undertaken by the research departments of prominent pharma industries and
market analysts are observant of the growth dynamics of global specialty
enzymes. Recently, a report by Allied Market Research titled “World Specialty
Enzymes (Pharmaceuticals, Biotechnology R&D, Diagnostics)”. As per the
report, specialty enzymes
market for biotechnology research, pharmaceuticals and diagnostics was valued
at $561.9 million in the year 2014 and would generate a revenue of $947.5
million by the end of 2020, growing at 9.4% CAGR amid the period 2015 - 2020.
